PRVA Stock Analysis: Buy, Sell, or Hold?
PRVA - Privia Health Group, Inc. Common Stock
$23.22
0.35 (1.53%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When PRVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PRVA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: PRVA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$34.05
Based on 7.6% avg growth
INTRINSIC VALUE TODAY
$21.14
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PRVA is currently trading at $23.22, which is considered oversold relative to its 30-day fair value range of $23.22 to $24.09. The stock's valuation (Forward PE: 21.9) is in line with its historical norms (22.6). Remarkably, the market is currently pricing in an annual earnings decline of 1.2% over the next few years. This pessimistic expectation contrasts with the company's recent 69.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PRVA is showing sideways momentum. Immediate support is located at $22.30, while resistance sits at $24.24.
Market Sentiment: PRVA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $31.25 (+36.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PRVA is showing sideways momentum. Immediate support is located at $22.30, while resistance sits at $24.24.
Market Sentiment: PRVA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $31.25 (+36.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$23.22 -
$24.09
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding PRVA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 36.6% below Wall St target ($31.25)
Fair Price Analysis
30-Day Fair Range
$23.22 -
$24.09
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$22.30
Resistance Level
$24.24
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
21.86
Wall Street Target
$31.25
(+36.6%)
Revenue Growth (YoY)
32.5%
Earnings Growth (YoY)
69.2%
Profit Margin
0.9%
Valuation Discount vs History
-1.2% cheaper
PE vs Historical
21.9 vs 22.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.2%
(market-implied from PE analysis)
1-Year Target
$22.60
(-1%)
2-Year Target
$22.32
(-2%)
3-Year Target
$22.06
(-4%)
3-Yr Target (if PE normalizes)
(PE: 22→23)
$22.80
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 11.2%)
$32.05
(+40%)
Base:
(SPY PE: 21.9, Growth: 11.2%)
$31.42
(+37%)
Bear:
(PE: 18.6, Growth: 11.2%)
$26.71
(+17%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (22x PE) as earnings recover.
Forward PE: 24.21 | Forward EPS (Implied): $0.96
Bull Case
$28.04
(+21%)
Analyst growth 15.0%, PE expands to 25.4
Base Case
$23.22
(0%)
Market implied 0.0%, PE stable at 24.2
Bear Case
$17.76
(-24%)
Severe decline -15.0%, PE contracts to 21.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.9 to 22.6
Stabilization Target:
$23.64
(+3.4%)
PE Expansion Potential:
+3.4%
Last updated: January 30, 2026 7:49 PM ET
Data refreshes hourly during market hours. Next update: 8:49 PM
Data refreshes hourly during market hours. Next update: 8:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$310 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$29 | 48 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 55 HOLD |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
12 analysts |
$43 | 63 BUY |
Advanced PRVA Option Strategies
Professional options setups generated by AI based on today's PRVA price and gamma walls.
